Browse by specialty

Public Medicine

In 2025, 3 Public Medicine providers had general (non-research) payments reported to CMS. Half received less than $285 for the year, and nine in ten received less than $1,655.

3providers with payments in 2025

$285median total for the year

$1,655nine in ten received less than

$839average total for the year

Providers with the largest 2025 totals

Ordered by 2025 general-payment totals as reported to CMS. A large total is not evidence of wrongdoing; context is below the table.

Provider	Location	2025 general	All payments 2019-2025 including research
Matthew Davis Mccarty	Cincinnati, OH	$1,997.83	$3,406.31
Tommy W Garnett	Wetumpka, AL	$284.89	$1,006.37
Liza Chabokrow	Austin, TX	$235.41	$1,376.87
Robert J Rosenstein	Mentor, OH	$0.00	$37.56
Kathleen Reilly-Fallon	Armonk, NY	$0.00	$219.22

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026).